Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2143
  • Home
  • Print this page
  • Email this page
CASE REPORT
Year : 2018  |  Volume : 66  |  Issue : 10  |  Page : 1483-1485

Uveitis in sporadic Blau syndrome: Long-term follow-up of a refractory case treated successfully with adalimumab


1 Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Medical Research Foundation, Porur, Tamil Nadu, India
2 Department of Ophthalmology, Sri Ramachandra Medical Centre, Sri Ramachandra University, Porur, Tamil Nadu, India
3 Department of Uvea and Ocular Pathology, Sankara Nethralaya, Medical Research Foundation, Chennai, Tamil Nadu, India

Correspondence Address:
Dr. Jyotirmay Biswas
Department of Uvea and Ocular Pathology, Sankara Nethralaya, Medical Research Foundation, 18/41, College Road, Chennai- - 600 006, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_629_18

Rights and Permissions

The classic entity of autosomal dominant Blau syndrome (BS) consists of arthritis, dermatitis, and uveitis, occurring as a result of mutations in the NOD2 gene pattern recognition receptor. Sporadic cases are those in which no known gene mutation is identifiable. Uveitis in BS can be refractory to conventional therapy. We report a case of sporadic Blau uveitis managed with adalimumab monotherapy after failing to respond to topical steroids, systemic steroids, methotrexate, and infliximab therapy sequentially. Uveitis resolved completely with adalimumab and the patient has had a disease-free period over a 2-year follow-up with bi-monthly injections for arthritis control.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed997    
    Printed19    
    Emailed0    
    PDF Downloaded184    
    Comments [Add]    

Recommend this journal